Display options
Cite
Perbtani YB, Westerveld DR, Yang DJ, et al. CYP2C19 genotype variability in patients with refractory gastroesophageal reflux after per-oral endoscopic myotomy (POEM). Endosc Int Open. 2021;9(6):E843-E847doi: 10.1055/a-1401-9853.
Perbtani, Y. B., Westerveld, D. R., Yang, D. J., & Draganov, P. V. (2021). CYP2C19 genotype variability in patients with refractory gastroesophageal reflux after per-oral endoscopic myotomy (POEM). Endoscopy international open, 9(6), E843-E847. https://doi.org/10.1055/a-1401-9853
Perbtani, Yaseen B, et al. "CYP2C19 genotype variability in patients with refractory gastroesophageal reflux after per-oral endoscopic myotomy (POEM)." Endoscopy international open vol. 9,6 (2021): E843-E847. doi: https://doi.org/10.1055/a-1401-9853
Perbtani YB, Westerveld DR, Yang DJ, Draganov PV. CYP2C19 genotype variability in patients with refractory gastroesophageal reflux after per-oral endoscopic myotomy (POEM). Endosc Int Open. 2021 Jun;9(6):E843-E847. doi: 10.1055/a-1401-9853. Epub 2021 May 27. PMID: 34079865; PMCID: PMC8159581.
Copy Download .nbib Format: NLM
Share it on

Endosc Int Open. 2021 Jun;9(6):E843-E847. doi: 10.1055/a-1401-9853. Epub 2021 May 27.

CYP2C19 genotype variability in patients with refractory gastroesophageal reflux after per-oral endoscopic myotomy (POEM).

Endoscopy international open

Yaseen B Perbtani, Donevan R Westerveld, Dennis J Yang, Peter V Draganov

Affiliations

  1. Department of Internal Medicine, University of Florida, Gainesville, Florida, United States.
  2. Division of Gastroenterology and Hepatology, University of Florida, Gainesville, Florida, United States.

PMID: 34079865 PMCID: PMC8159581 DOI: 10.1055/a-1401-9853

[No abstract available.]

The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Conflict of interest statement

Competing interests The authors declare that they have no conflict of interest.

References

  1. Neurogastroenterol Motil. 2015 Feb;27(2):160-74 - PubMed
  2. Esophagus. 2020 Jan;17(1):3-10 - PubMed
  3. Br J Clin Pharmacol. 1998 Apr;45(4):369-75 - PubMed
  4. Gastroenterol Rep (Oxf). 2015 Feb;3(1):41-53 - PubMed
  5. Aliment Pharmacol Ther. 2009 Nov 15;30(10):1030-8 - PubMed
  6. Endoscopy. 2010 Apr;42(4):265-71 - PubMed
  7. J Gastroenterol Hepatol. 2016 Apr;31(4):716-26 - PubMed
  8. Expert Opin Drug Metab Toxicol. 2018 Apr;14(4):447-460 - PubMed
  9. Clin Pharmacol Ther. 2011 Aug;90(2):328-32 - PubMed
  10. Gastrointest Endosc. 2018 Apr;87(4):934-943.e18 - PubMed
  11. Clin Pharmacol Ther. 2002 Oct;72(4):453-60 - PubMed
  12. Eur J Clin Pharmacol. 2009 Jul;65(7):693-8 - PubMed
  13. Surg Endosc. 2016 Mar;30(3):947-52 - PubMed

Publication Types